z-logo
open-access-imgOpen Access
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients--authors' response
Author(s) -
D. Rey,
Bruno Hoën,
P. Chavanet,
MariePaule Schmitt,
Guillaume Hoizey,
P. Meyer,
Gilles Peytavin,
Bruno Spire,
Clotilde Allavena,
Myriam Diemer,
T. May,
J.L. Schmit,
Michel Duong,
Vincent Cálvez,
Jean-Marie Lang
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp064
Subject(s) - nevirapine , lamivudine , tenofovir , medicine , virology , human immunodeficiency virus (hiv) , emtricitabine , viral load , antiretroviral therapy , virus , hepatitis b virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom